0001209191-23-052884.txt : 20231016
0001209191-23-052884.hdr.sgml : 20231016
20231016173007
ACCESSION NUMBER: 0001209191-23-052884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231012
FILED AS OF DATE: 20231016
DATE AS OF CHANGE: 20231016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ndu Adora
CENTRAL INDEX KEY: 0001865210
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 231328068
MAIL ADDRESS:
STREET 1: C/O DBV TECHNOLOGIES S.A.
STREET 2: 177-181 AVENUE PIERRE BROSSOLETTE
CITY: MONTROUGE
STATE: I0
ZIP: 92120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12830 EL CAMINO REAL
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 12830 EL CAMINO REAL
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-12
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001865210
Ndu Adora
C/O ACADIA PHARMACEUTICALS INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
1
0
0
0
0
Common Stock
2023-10-12
4
M
0
4381
A
4381
D
Restricted Stock Units
2023-10-12
4
M
0
4381
0.00
D
Common Stock
4381
4381
D
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
The restricted stock units shall vest in two equal annual installments commencing on the first anniversary of the grant date.
/s/ Austin D. Kim, Attorney-in-Fact
2023-10-16